Explain this page
Arphra AIPlain-English read on Ducommun Incorporated’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Quality composite
BMixed
A snapshot of the latest fiscal year’s margins, returns on capital, balance-sheet strength and efficiency, computed from the income statement, balance sheet and cash-flow rows. Source income / balance / cash_flow.
Profitability
Gross margin26.9%
Operating margin-3.9%
Net margin-4.1%
ROE-5.1%
ROA-2.9%
ROIC-2.6%
Liquidity & leverage
Current ratio3.50×
Quick ratio2.47×
Debt / equity0.52×
Net debt / EBITDA119.36×
Interest coverage-3×
Efficiency & per-share
Asset turnover0.70×
Inventory days111
Days sales out.166
FCF / share$-3.26
Book value / share$44.31
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Headline | ||||||||
| Market cap | — | — | — | $940.51M | $1.42B | — | — | — |
| Enterprise value | — | — | — | $1.18B | $1.72B | — | — | — |
| Multiples | ||||||||
| P / E | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | 1.49 | 2.09 | — | — | — |
| EV / FCF | — | — | — | 58.63 | -35.40 | — | — | — |
| Yields | ||||||||
| Earnings yield | — | — | — | +3.35% | -2.63% | — | — | — |
| Free cash flow yield | — | — | — | +2.13% | -3.42% | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross margin | +22.07% | +20.25% | +21.56% | +25.08% | +26.87% | +24.27% | +24.23% | +24.17% |
| Operating margin | +7.57% | +5.58% | +3.82% | +6.64% | -3.92% | +2.12% | +2.17% | +2.14% |
| EBITDA margin | +32.55% | +10.71% | +9.21% | +10.89% | +0.31% | +6.92% | +6.96% | +6.83% |
| EBIT margin | +28.15% | +6.30% | +4.91% | +6.64% | -3.78% | +2.64% | +2.66% | +2.60% |
| Pre-tax margin | +26.41% | +4.68% | +2.16% | +4.69% | -5.31% | +0.52% | +0.52% | +0.50% |
| Net margin | +21.00% | +4.04% | +2.10% | +4.00% | -4.12% | +0.65% | +0.66% | +0.65% |
| Cost structure | ||||||||
| Cost of revenue / sales | +77.93% | +79.75% | +78.44% | +74.92% | +73.13% | +76.80% | +75.28% | +77.26% |
| R&D intensity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| SG&A intensity | +14.50% | +13.80% | +15.82% | +17.62% | +17.51% | +17.12% | +17.33% | +16.48% |
| Effective tax rate | +20.50% | +13.60% | +2.75% | +14.66% | — | +8.36% | +8.47% | +8.77% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Returns | ||||||||
| Return on equity (ROE) | +28.56% | +5.47% | +2.50% | +4.61% | -5.13% | +0.77% | +0.80% | +0.76% |
| Return on assets (ROA) | +13.85% | +2.82% | +1.42% | +2.80% | -2.86% | +0.45% | +0.46% | +0.46% |
| Return on capital (ROC) | +6.15% | +4.92% | +3.10% | +5.47% | -3.20% | +1.72% | +1.79% | +1.71% |
| Return on invested capital (ROIC) | +17.04% | +3.56% | +1.71% | +3.30% | -2.40% | +0.53% | +0.55% | +0.52% |
| Asset turnover | +65.94% | +69.75% | +67.53% | +69.85% | +69.53% | +69.03% | +69.54% | +70.56% |
| DuPont · ROE decomposition | ||||||||
| Net margin | +21.00% | +4.04% | +2.10% | +4.00% | -4.12% | +0.65% | +0.66% | +0.65% |
| Asset turnover (× revenue / assets) | +65.94% | +69.75% | +67.53% | +69.85% | +69.53% | +69.03% | +69.54% | +70.56% |
| Equity multiplier (× assets / equity) | +206.22% | +194.22% | +176.22% | +164.99% | +179.16% | +170.81% | +174.95% | +164.61% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||
| Asset turnover | 0.66 | 0.70 | 0.68 | 0.70 | 0.70 | 0.69 | 0.70 | 0.71 |
| Fixed-asset turnover | 4.76 | 5.06 | 5.37 | 5.68 | 5.60 | — | — | — |
| Inventory turnover | 3.33 | 3.32 | 2.87 | 2.99 | 3.30 | — | — | — |
| Receivables turnover | 2.60 | 2.41 | 2.68 | 2.53 | 2.20 | — | — | — |
| Payables turnover | 7.61 | 6.30 | 8.22 | 7.78 | 8.08 | — | — | — |
| Days outstanding | ||||||||
| Days sales outstanding (DSO) | 140.63 | 151.24 | 136.15 | 144.00 | 165.65 | — | — | — |
| Days inventory outstanding (DIO) | 109.54 | 109.97 | 127.23 | 121.95 | 110.62 | — | — | — |
| Days payables outstanding (DPO) | 47.94 | 57.90 | 44.42 | 46.94 | 45.18 | — | — | — |
| Cash conversion cycle | 202.23 | 203.31 | 218.96 | 219.00 | 231.09 | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | -0.00 | 1.14 | 1.95 | 1.09 | 0.98 | 2.26 | 2.18 | 2.29 |
| FCF / Net income | -0.13 | 0.45 | 0.72 | 0.64 | 1.43 | -0.96 | -0.90 | -0.93 |
| FCF margin | -2.70% | +1.82% | +1.53% | +2.55% | -5.90% | -0.63% | -0.60% | -0.61% |
| OCF margin | -0.09% | +4.59% | +4.10% | +4.35% | -4.05% | +1.48% | +1.44% | +1.50% |
| CapEx / Revenue | +2.61% | +2.76% | +2.58% | +1.80% | +1.85% | +2.06% | +2.13% | +2.03% |
| CapEx / D&A | 0.59 | 0.63 | 0.60 | 0.42 | 0.45 | — | — | — |
| Stock-based comp / Revenue | +1.74% | +1.51% | +1.99% | +2.27% | +2.97% | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| EPS · diluted | 11.06 | 2.33 | 1.14 | 2.10 | -2.27 | 4.14 | 5.08 | 5.90 |
| EPS · basic | 11.41 | 2.38 | 1.16 | 2.13 | -2.27 | 4.19 | 5.18 | 6.03 |
| Book value / share | 38.74 | 42.53 | 45.53 | 45.46 | 44.31 | 50.41 | 52.68 | 60.23 |
| Tangible BV / share | 10.54 | 15.80 | 16.11 | 19.21 | 19.05 | 50.41 | 52.68 | 60.23 |
| Sales / share | 52.68 | 57.62 | 54.18 | 52.39 | 55.20 | 59.44 | 64.09 | 69.96 |
| Operating CF / share | -0.05 | 2.64 | 2.22 | 2.28 | -2.24 | 0.88 | 0.92 | 1.05 |
| Free cash flow / share | -1.42 | 1.05 | 0.83 | 1.34 | -3.26 | -0.37 | -0.38 | -0.43 |
| Dividends / share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payout ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Retention ratio | +100.00% | +100.00% | +100.00% | +100.00% | +100.00% | +100.00% | +100.00% | +100.00% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 7y CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Top-line | |||||||||
| Revenue · YoY | — | +10.40% | +6.24% | +3.90% | +4.85% | +7.13% | +9.14% | +8.22% | +7.11% |
| Gross profit · YoY | — | +1.29% | +13.09% | +20.88% | +12.34% | -3.23% | +8.94% | +7.97% | +8.50% |
| Profit | |||||||||
| Operating income · YoY | — | -18.60% | -27.32% | +80.55% | -161.87% | +157.91% | +11.79% | +6.56% | -10.61% |
| EBITDA · YoY | — | -63.67% | -8.64% | +22.84% | -97.06% | +2326.41% | +9.78% | +6.29% | -14.31% |
| Net income · YoY | — | -78.76% | -44.67% | +97.73% | -207.76% | +117.04% | +10.18% | +6.75% | -34.78% |
| Operating | |||||||||
| EBIT · YoY | — | -75.29% | -17.24% | +40.53% | -159.64% | +174.89% | +10.17% | +5.47% | -23.80% |
| R&D · YoY | — | — | — | — | — | — | — | — | — |
| Per-share | |||||||||
| EPS · diluted · YoY | — | -78.93% | -51.07% | +84.21% | -208.10% | +282.45% | +22.74% | +16.10% | -8.58% |
| EPS · basic · YoY | — | -79.14% | -51.26% | +83.62% | -206.57% | +284.63% | +23.64% | +16.42% | -8.70% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Leverage | ||||||||
| Total debt | $320.59M | $282.84M | $295.59M | $272.15M | $345.83M | $340.42M | $375.94M | $404.22M |
| Net debt | $244.28M | $236.6M | $252.73M | $235.01M | $300.54M | $293.27M | $324.32M | $347.65M |
| Net debt / EBITDA | 1.16 | 3.10 | 3.62 | 2.74 | 119.36 | 4.80 | 4.84 | 4.88 |
| Debt / equity | 0.68 | 0.54 | 0.46 | 0.40 | 0.52 | 0.45 | 0.47 | 0.45 |
| Debt / assets | +32.76% | +27.69% | +26.37% | +24.17% | +29.15% | +26.60% | +27.11% | +27.33% |
| Equity / assets | +48.49% | +51.49% | +56.75% | +60.61% | +55.82% | +58.55% | +57.16% | +60.75% |
| Coverage | ||||||||
| EBITDA / interest expense | 18.78 | 6.60 | 3.36 | 5.60 | 0.20 | 3.35 | 3.45 | 3.32 |
| Operating income / interest | 4.37 | 3.44 | 1.39 | 3.41 | -2.55 | 1.03 | 1.07 | 1.04 |
| Interest expense | $11.19M | $11.57M | $20.77M | $15.3M | $12.68M | $18.24M | $19.47M | $21.44M |
| Liquidity | ||||||||
| Current ratio | 3.03 | 2.64 | 2.99 | 3.24 | 3.50 | — | — | — |
| Quick ratio | 2.00 | 1.71 | 1.77 | 1.98 | 2.34 | — | — | — |
| Cash ratio | 0.47 | 0.23 | 0.23 | 0.21 | 0.25 | — | — | — |
| Working capital | $330.01M | $327.9M | $365.87M | $392.61M | $446.88M | — | — | — |
| Working capital / revenue | +51.13% | +46.02% | +48.33% | +49.92% | +54.18% | — | — | — |
Sourced from key_metrics + financial_ratios (loaded by load_fundamentals_extended.py).
Valuation
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| P / E | — | — |
| P / B | — | — |
| EV / EBITDA | — | — |
| EV / Sales | 2.09x | 1.49x |
| Earnings yield | -2.6% | 3.3% |
| FCF yield | -3.4% | 2.1% |
Returns
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| Gross margin | — | — |
| Operating margin | — | — |
| Net margin | — | — |
| ROE | -5.6% | 4.6% |
| ROA | -3.1% | 2.8% |
| ROIC | 5.7% | 4.6% |
Leverage & liquidity
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| Debt / equity | — | — |
| Net debt / EBITDA | 2.80 | 2.74 |
| Interest coverage | — | — |
| Current ratio | 3.50x | 3.24x |
| Quick ratio | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).